Anton H. van Kaam
VU University Amsterdam
131 Papers
151 Citations
Anton H. van Kaam is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Medicine & Bronchopulmonary dysplasia. The author has an hindex of 28, co-authored 77 publications. Previous affiliations of Anton H. van Kaam include University of Amsterdam & Boston Children's Hospital.
Chat about Author
Papers
Fecal Volatile Metabolomics Predict Gram-Negative Late-Onset Sepsis in Preterm Infants: A Nationwide Case-Control Study
Nina Frerichs,Sofia el Manouni el Hassani,Nancy Deianova,Mirjam M. van Weissenbruch,Anton H. van Kaam,Daniel C. Vijlbrief,Johannes B. van Goudoever,Christian V. Hulzebos,Boris W. Kramer,Esther J. D’Haens,Veerle Cossey,Willem P. de Boode,Wouter J. de Jonge,Alfian Wicaksono,James A. Covington,Marc A. Benninga,Nanne K. H. de Boer,Hendrik J. Niemarkt,Tim G. J. de Meij +18 more
TL;DR: In this paper , the authors proposed that fecal volatile organic compounds (VOCs), reflecting microbiota composition and function, could serve as a non-invasive biomarker for preclinical pathogen-specific LOS detection.
Exhaled Volatile Organic Compounds for Early Prediction of Bronchopulmonary Dysplasia in Infants Born Preterm.
Michelle Romijn,Anton H. van Kaam,Dominic William Fenn,Lieuwe D. J. Bos,Chris H. B. van den Akker,Martijn J. J. Finken,Joost Rotteveel,Julia Cerullo,Paul Brinkman,Wes Onland +9 more
TL;DR: In this paper , the authors investigated the predictive performances of exhaled breath volatile organic compounds (VOCs) for development of bronchopulmonary dysplasia (BPD) in infants born preterm.
9
Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis
Wes Onland,A. D. De Jaegere,Martin Offringa,Anton H. van Kaam +3 more
TL;DR: Recommendations for optimal dexamethasone doses for preterm infants at risk for chronic lung disease cannot be based on current evidence, and a well-designed, large, randomized, controlled trial is urgently needed to establish the optimal dose.
8
An atypical course of coxsackievirus A6 associated hand, foot and mouth disease in extremely low birth weight preterm twins.
Andrea H. L. Bruning,Sabine M. G. van der Sanden,Amber E. ten Hoedt,Katja C. Wolthers,Anton H. van Kaam,Dasja Pajkrt +5 more
TL;DR: An atypical course of CV-A6-associated HFMD in extremely low birth weight twins is described and genetically closely related to international strains isolated from HFMD outbreaks is described.
8
Cardiorespiratory monitoring in the delivery room using transcutaneous electromyography.
Ruud W. van Leuteren,Eline Kho,Eline Kho,Cornelia G. de Waal,Arjan B. te Pas,Hylke H. Salverda,Frans H. de Jongh,Frans H. de Jongh,Anton H. van Kaam,Anton H. van Kaam,Gerard J. Hutten,Gerard J. Hutten +11 more
TL;DR: Monitoring vital signs with dEMG in the DR is feasible and fast, making d EMG promising for future DR studies and peak, tonic and amplitude diaphragm activity can be detected and described withdEMG.
8